Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants - Wikidata - awgldk - TriplyDB

Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants

Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants

http://www.wikidata.org/entity/Q33862255

about

Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)Somatic mutations in solid tumors: a spectrum at the service of diagnostic armamentarium or an indecipherable puzzle? The morphological eyes looking for BRAF and somatic molecular detections on cyto-histological samples Genomic profile of ovarian carcinomas RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transition and metastasis BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumors Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas Risk prediction model for epithelial ovarian cancer using molecular markers and clinical characteristics.Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells.The molecular pathology of ovarian serous borderline tumors.The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.Role of the protein kinase BRAF in the pathogenesis of endometriosis.Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma.Fascin-1 expression as stratification marker in borderline epithelial tumours of the ovary.Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation.Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma.Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.A guided tour of selected issues pertaining to metastatic carcinomas involving or originating from the gynecologic tract.KRAS mutation of extraovarian implants of serous borderline tumor: prognostic indicator for adverse clinical outcome.Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

P2860

Q26852127-57C96ED7-57FD-4FB6-A568-BF96478B484F Q28070226-D94AAAA7-E105-4979-A526-92357115D436 Q33913984-D934995D-3F71-4B34-89B4-E615E8FD829B Q34334385-20214DB3-9F3D-4273-8CBA-2E62DA1C9B29 Q35041937-BB1558F4-B777-4A0E-85E8-4A35FDF704AC Q35060446-A30417AB-8044-49F2-A7B2-AD39B36801BF Q36199823-83BAB7C4-903B-4FFB-B2A8-E97946A7F6AF Q36850060-A4544AD0-F5A2-4DBA-9BB9-633A290EE193 Q36855249-7E59EE36-BE71-4AA8-BE75-12BBA78E71F4 Q38787667-1F8F455E-F305-4709-9B0B-996007163E55 Q39844384-DD9BA0E6-A529-4924-BB05-4BD31A05DFEE Q40057309-5ED5E5C4-FA2C-4141-911B-AE9354826EF8 Q40547169-D9FE530D-169E-4C1A-8DA8-57EB7C86C762 Q41553206-21012F93-ADE1-4105-BFF3-ABF86E527AD0 Q46879650-C6BAD36F-477A-4A4C-A373-5C7068B53511 Q48124146-E20C28ED-3520-4129-9861-A21AC2225B71 Q49724000-07207D78-B84E-4DD1-8F14-FC875DE1D084 Q50063073-58B28AAE-A11A-4F24-B759-55C563FC909C Q52725941-C0946FF1-E522-402A-B55A-61C78E44F67C

P2860

Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants

http://www.wikidata.org/entity/Q33862255

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Mutational analysis of BRAF an ...... associated peritoneal implants

@ast

Mutational analysis of BRAF an ...... associated peritoneal implants

@en

type

label

Mutational analysis of BRAF an ...... associated peritoneal implants

@ast

Mutational analysis of BRAF an ...... associated peritoneal implants

@en

prefLabel

Mutational analysis of BRAF an ...... associated peritoneal implants

@ast

Mutational analysis of BRAF an ...... associated peritoneal implants

@en

P1433

Q33862255-07902E0D-0ACE-4534-B6BB-F89AE6FB7B6E

P1476

Q33862255-5F7EA7D7-9CE9-4682-9448-591D73601AF4

P2093

Q33862255-076A7BFF-CC33-4EFA-A379-8EAF9598EB4C

Q33862255-07B5602B-573C-4BC4-B3AF-9FEEE31EC7FC

Q33862255-0A00D162-C715-4E3F-AEF4-A5B7865FE2BD

Q33862255-190F58F7-CF26-40D2-B494-8CCC146787F1

Q33862255-2A7826F1-153D-4C95-8435-270748BE5DFB

Q33862255-76FEDDB4-7142-44E8-88E7-6394C6771EC9

Q33862255-8DAF2715-8568-44BD-BAF1-924651F4E8E6

P2860

Q33862255-053F6CB5-FF85-4339-9DB1-F14BD5547C57

Q33862255-06018EA0-0748-4F2F-B78A-89B99ABF81D1

Q33862255-3E67B481-07BF-4808-9D13-3FDDA37F17A3

Q33862255-46E7D54A-43C7-449E-91D7-95A368055F59

Q33862255-47449D00-E68F-46A1-B6F0-C056D73C0C22

Q33862255-52D9185E-5918-4E2B-B852-2AB497F78D9F

Q33862255-6F110107-C485-4197-BFBF-1F6CCB8E13B9

Q33862255-876BE75F-B1AF-48DC-889B-43FA00A1F8F6

Q33862255-9AADCBDD-4A07-4635-8DEF-3CD2412C4E79

Q33862255-A092F6B3-57DD-447E-8C08-18EECAF20B92

P304

Q33862255-F98410A6-CE26-4138-AF56-D6C4D5A63938

P31

Q33862255-80A94F11-4141-4D8F-8F41-E3AA0B4CDF8C

P356

Q33862255-0C4C54B6-E7E6-4602-A4D1-8C38CD6421A7

P433

Q33862255-D29FD8C2-5864-4EBD-B736-A209C0373397

P478

Q33862255-04BADDBB-8F85-43B4-964D-9B604E5B90DE

P50

Q33862255-04EA04B2-A0BE-4638-989C-CF91D7F093E8

Q33862255-890CEFB0-ECAB-4314-A097-D5F368F4F300

P577

Q33862255-6C2EB54C-CE8F-42FF-815F-A6E1FBA8B134

P698

Q33862255-8D28F2F0-95C5-4B50-8ACC-6F00E4BA6217

P932

Q33862255-BE6CE7F0-F291-4C36-8311-F197F921E944

P356

P1433

The Journal of Pathology

P1476

Mutational analysis of BRAF an ...... associated peritoneal implants

@en

P2093

Charlotte G Hannibal

http://www.w3.org/2001/XMLSchema#string

Felix Zeppernick

http://www.w3.org/2001/XMLSchema#string

Ie-Ming Shih

http://www.w3.org/2001/XMLSchema#string

Jette Junge

http://www.w3.org/2001/XMLSchema#string

Leslie Cope

http://www.w3.org/2001/XMLSchema#string

Robert J Kurman

http://www.w3.org/2001/XMLSchema#string

Russell Vang

http://www.w3.org/2001/XMLSchema#string

P2860

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

K-RAS mutations in ovarian and extraovarian lesions of serous tumors of borderline malignancy.

K-ras mutations in Müllerian inclusion cysts associated with serous borderline tumors of the ovary.

Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.

Whole exome sequence analysis of serous borderline tumors of the ovary.

Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis.

Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors.

Low-grade serous carcinomas of the ovary contain very few point mutations

Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR.

EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients.

P304

16-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PATH.4293

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

232

http://www.w3.org/2001/XMLSchema#string

P50

Susanne Krüger Kjaer

Laura Ardighieri

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24307542

http://www.w3.org/2001/XMLSchema#string

P932

4086471

http://www.w3.org/2001/XMLSchema#string